MeSH term
Frequency | Condition_Probility | Alleles | 83 | 1.0 |
Case-Control Studies | 6 | 0.0 |
Comparative Study | 71 | 0.0 |
Complement 3/genetics | 5 | 13.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Haptoglobins/genetics | 15 | 30.0 |
Humans | 422 | 0.0 |
Lactoylglutathione Lyase/genetics | 13 | 30.0 |
Moscow | 2 | 8.0 |
Phenotype | 155 | 1.0 |
Phosphoglucomutase/genetics | 31 | 67.0 |
Polymorphism, Genetic | 56 | 1.0 |
Transferrin/genetics | 15 | 30.0 |
Aged | 22 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Cell Count | 2 | 0.0 |
Female | 163 | 0.0 |
Male | 166 | 0.0 |
Middle Aged | 35 | 0.0 |
Reference Values | 3 | 0.0 |
Blood Group Antigens/*genetics | 28 | 27.0 |
Chi-Square Distribution | 4 | 0.0 |
Cluster Analysis | 4 | 2.0 |
Ethnic Groups/*genetics | 17 | 8.0 |
Gene Frequency | 118 | 2.0 |
Haplotypes | 13 | 0.0 |
*Polymorphism, Genetic | 97 | 2.0 |
Research Support, Non-U.S. Gov't | 128 | 0.0 |
Residence Characteristics | 2 | 10.0 |
English Abstract | 75 | 0.0 |
Treatment Outcome | 3 | 0.0 |
*Genetic Markers | 30 | 9.0 |
*Heterozygote | 4 | 1.0 |
ABO Blood-Group System/*genetics | 8 | 17.0 |
Acid Phosphatase/genetics | 13 | 39.0 |
Erythrocytes/*enzymology | 77 | 14.0 |
Russia | 15 | 15.0 |
Electrophoresis, Starch Gel | 23 | 16.0 |
Haplotypes/genetics | 3 | 0.0 |
Japan | 12 | 0.0 |
Phosphoglucomutase/*genetics | 87 | 82.0 |
Polymerase Chain Reaction | 7 | 0.0 |
Polymorphism, Genetic/genetics | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Variation (Genetics)/*genetics | 4 | 1.0 |
Creatinine/blood | 2 | 0.0 |
Immunohistochemistry | 10 | 0.0 |
Macrophages/pathology | 2 | 1.0 |
*Carboxylesterase | 25 | 22.0 |
Carboxylic Ester Hydrolases/*genetics | 4 | 7.0 |
*Gene Pool | 12 | 63.0 |
Geography | 4 | 6.0 |
Lactoylglutathione Lyase/*genetics | 3 | 7.0 |
Phosphogluconate Dehydrogenase/*genetics | 5 | 41.0 |
Adult | 74 | 0.0 |
Evolution | 4 | 1.0 |
Genetics, Population | 8 | 2.0 |
Genotype | 15 | 0.0 |
Heterozygote | 18 | 0.0 |
Italy/epidemiology | 5 | 2.0 |
Linear Models | 2 | 0.0 |
Maternal Age | 2 | 2.0 |
*Phosphoglucomutase | 6 | 75.0 |
Phosphoproteins/*genetics | 4 | 1.0 |
Polymorphism, Genetic/*genetics | 18 | 1.0 |
Selection (Genetics) | 2 | 1.0 |
Gene Frequency/*genetics | 9 | 6.0 |
Infant, Newborn | 13 | 0.0 |
Models, Genetic | 3 | 0.0 |
*Parents | 2 | 20.0 |
*Selection (Genetics) | 4 | 6.0 |
Homozygote | 4 | 0.0 |
*Gene Frequency | 49 | 9.0 |
Histocompatibility Testing | 2 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Blood Proteins/*genetics | 31 | 19.0 |
Gene Frequency/genetics | 8 | 1.0 |
*Genetics, Population | 38 | 10.0 |
Moldova | 2 | 66.0 |
Rh-Hr Blood-Group System/*genetics | 2 | 2.0 |
Child | 34 | 0.0 |
Isoelectric Focusing | 46 | 8.0 |
DNA/genetics | 4 | 0.0 |
Ethnic Groups/genetics | 2 | 1.0 |
Predictive Value of Tests | 2 | 0.0 |
Altitude | 2 | 8.0 |
Discriminant Analysis | 2 | 2.0 |
Italy | 27 | 4.0 |
Temperature | 2 | 0.0 |
Animals | 34 | 0.0 |
Chromosome Banding | 3 | 0.0 |
Chromosome Mapping | 40 | 0.0 |
Hamsters | 8 | 0.0 |
Hybrid Cells | 9 | 0.0 |
Mice | 9 | 0.0 |
Polymorphism, Restriction Fragment Length | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 31 | 0.0 |
Enzymes/*genetics | 15 | 35.0 |
Genetic Markers/*genetics | 3 | 2.0 |
Indians, South American/*genetics | 4 | 6.0 |
Multivariate Analysis | 3 | 0.0 |
Peru | 2 | 4.0 |
Variation (Genetics) | 17 | 1.0 |
Asian Continental Ancestry Group | 9 | 3.0 |
Carboxylic Ester Hydrolases/blood/*genetics | 3 | 27.0 |
China | 9 | 1.0 |
Phosphoglucomutase/blood/*genetics | 21 | 100.0 |
Data Interpretation, Statistical | 4 | 1.0 |
Haptoglobins/*genetics | 2 | 5.0 |
*Phenotype | 12 | 4.0 |
Asian Continental Ancestry Group/genetics | 4 | 1.0 |
European Continental Ancestry Group/genetics | 9 | 1.0 |
Genetic Markers | 59 | 2.0 |
Mutation | 5 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
ABO Blood-Group System/genetics | 10 | 23.0 |
Rh-Hr Blood-Group System/genetics | 9 | 32.0 |
Sampling Studies | 2 | 1.0 |
Spain | 8 | 2.0 |
*Variation (Genetics) | 17 | 1.0 |
Base Sequence | 9 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Linkage (Genetics) | 24 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
*Mutation | 2 | 0.0 |
Swine/*genetics | 2 | 1.0 |
DNA Primers | 4 | 0.0 |
European Continental Ancestry Group | 7 | 1.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
Isoenzymes/genetics | 12 | 3.0 |
Pedigree | 41 | 0.0 |
Africa/ethnology | 2 | 4.0 |
African Continental Ancestry Group/*genetics | 3 | 1.0 |
Demography | 4 | 3.0 |
Ecuador | 3 | 27.0 |
Emigration and Immigration | 4 | 8.0 |
Enzymes/genetics | 9 | 27.0 |
Phylogeny | 2 | 0.0 |
Cell Line | 7 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Factor Analysis, Statistical | 2 | 5.0 |
Heterozygote Detection | 7 | 1.0 |
Siberia | 11 | 28.0 |
Acid Phosphatase/blood/genetics | 5 | 71.0 |
Protease Inhibitors/metabolism | 2 | 6.0 |
Vitamin D-Binding Protein/genetics | 5 | 18.0 |
Brazil | 4 | 1.0 |
Biological Markers | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Binding Sites/genetics | 3 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Adolescent | 30 | 0.0 |
Blood Group Antigens/genetics | 17 | 28.0 |
Adenosine Deaminase/genetics | 6 | 27.0 |
Adenylate Kinase/genetics | 9 | 37.0 |
Alanine Transaminase/genetics | 2 | 22.0 |
Carboxylic Ester Hydrolases/genetics | 12 | 40.0 |
Erythrocytes/enzymology | 32 | 8.0 |
Phosphogluconate Dehydrogenase | 2 | 50.0 |
Phosphoric Monoester Hydrolases/genetics | 2 | 2.0 |
Paternity | 10 | 13.0 |
Poland | 10 | 7.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Antigens, CD/analysis | 3 | 0.0 |
Antigens, Differentiation, Myelomonocytic/analysis | 3 | 0.0 |
HLA Antigens/*genetics | 3 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Isoenzymes/*genetics | 21 | 4.0 |
Karyotyping | 10 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Recombination, Genetic | 15 | 1.0 |
Forensic Medicine/methods | 2 | 5.0 |
Acid Phosphatase/*genetics | 3 | 8.0 |
Chile | 3 | 5.0 |
Isoantigens/genetics | 2 | 10.0 |
*Isoelectric Focusing | 9 | 37.0 |
Semen/*enzymology | 4 | 20.0 |
Genetic Markers/genetics | 8 | 1.0 |
Phosphoglucomutase/*metabolism | 4 | 57.0 |
Pregnancy | 24 | 0.0 |
Immunoenzyme Techniques | 4 | 0.0 |
Chronic Disease | 2 | 0.0 |
France | 4 | 1.0 |
*Genetic Heterogeneity | 2 | 1.0 |
Carrier Proteins/*genetics | 5 | 0.0 |
*Chromosome Mapping | 19 | 1.0 |
*Chromosomes, Human, Pair 1 | 9 | 2.0 |
Rats | 5 | 0.0 |
Benin | 3 | 50.0 |
Carbonic Anhydrases/genetics | 2 | 22.0 |
Child, Preschool | 7 | 0.0 |
Glucosephosphate Dehydrogenase/genetics | 4 | 4.0 |
Infant | 5 | 0.0 |
Marriage | 2 | 8.0 |
Histocompatibility Antigens Class II/analysis | 2 | 1.0 |
S100 Proteins/analysis | 2 | 1.0 |
Molecular Weight | 3 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Tumor Markers, Biological/analysis | 2 | 0.0 |
European Continental Ancestry Group/*genetics | 4 | 1.0 |
India/ethnology | 3 | 4.0 |
Hungary | 2 | 3.0 |
Blood Protein Electrophoresis | 10 | 9.0 |
Consanguinity | 5 | 1.0 |
Europe/epidemiology | 2 | 2.0 |
Isoenzymes/blood/*genetics | 8 | 36.0 |
Blood Proteins/genetics | 10 | 17.0 |
Greece/ethnology | 2 | 10.0 |
History, Ancient | 2 | 11.0 |
Asian Continental Ancestry Group/*genetics | 8 | 2.0 |
Up-Regulation | 2 | 0.0 |
Pregnancy in Diabetics/enzymology/*genetics | 2 | 100.0 |
Isoenzymes/blood/genetics | 4 | 23.0 |
Erythrocytes/*metabolism | 3 | 1.0 |
*Indians, North American | 2 | 6.0 |
*Indians, South American | 6 | 26.0 |
Glucose-6-Phosphate Isomerase/genetics | 3 | 27.0 |
Analysis of Variance | 2 | 0.0 |
Electrophoresis, Cellulose Acetate | 3 | 7.0 |
Fetal Macrosomia/*genetics | 2 | 100.0 |
Pregnancy in Diabetics/*genetics | 2 | 66.0 |
Cloning, Molecular | 2 | 0.0 |
Multigene Family | 3 | 0.0 |
Rabbits | 3 | 0.0 |
*Linkage (Genetics) | 26 | 2.0 |
DNA Probes | 3 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Isoenzymes/*blood | 6 | 13.0 |
Leukocytes/enzymology | 3 | 2.0 |
Phosphoglucomutase/*blood | 14 | 73.0 |
Regression Analysis | 3 | 0.0 |
Italy/ethnology | 2 | 5.0 |
*Alleles | 10 | 0.0 |
*Blood Group Antigens | 15 | 28.0 |
*Continental Population Groups | 2 | 7.0 |
Australia | 5 | 2.0 |
Tajikistan | 2 | 100.0 |
Inuits/*genetics | 3 | 23.0 |
Lod Score | 12 | 1.0 |
India | 12 | 3.0 |
Language | 2 | 8.0 |
Lactoylglutathione Lyase/analysis | 2 | 66.0 |
Phosphoglucomutase/analysis | 5 | 50.0 |
DNA | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Complement 8/*genetics | 2 | 15.0 |
Adenosine Deaminase/blood/genetics | 2 | 50.0 |
Carboxylic Ester Hydrolases/blood/genetics | 2 | 40.0 |
MNSs Blood-Group System/genetics | 5 | 45.0 |
Phosphoglucomutase/blood/genetics | 4 | 80.0 |
Phosphogluconate Dehydrogenase/blood/genetics | 2 | 40.0 |
*Infant, Newborn | 2 | 4.0 |
Cameroon | 2 | 9.0 |
Enzymes/blood/genetics | 2 | 100.0 |
Hemoglobins/genetics | 6 | 24.0 |
Crossing Over, Genetic | 2 | 2.0 |
*Paternity | 13 | 17.0 |
Vitamin D-Binding Protein/*genetics | 3 | 5.0 |
Risk Factors | 2 | 0.0 |
Placenta/enzymology | 6 | 7.0 |
Acid Phosphatase/blood | 9 | 12.0 |
Isoelectric Focusing/*methods | 7 | 18.0 |
Phosphoglucomutase/blood | 9 | 56.0 |
Blood Grouping and Crossmatching | 5 | 7.0 |
HLA Antigens/genetics | 5 | 1.0 |
Immunoglobulin Allotypes/genetics | 3 | 17.0 |
Probability | 2 | 0.0 |
USSR | 5 | 27.0 |
Phosphogluconate Dehydrogenase/genetics | 14 | 53.0 |
China/ethnology | 5 | 2.0 |
Taiwan | 4 | 2.0 |
Phosphoglucomutase/*genetics/isolation & purification | 2 | 100.0 |
African Continental Ancestry Group/genetics | 3 | 1.0 |
South Africa | 6 | 4.0 |
African Continental Ancestry Group | 6 | 2.0 |
Genes, Dominant | 2 | 0.0 |
Ethnic Groups | 5 | 2.0 |
Immunoglobulins/genetics | 2 | 5.0 |
Oxidoreductases/*genetics | 2 | 2.0 |
Hydrolases/*genetics | 2 | 8.0 |
Arctic Regions | 4 | 50.0 |
*Ethnic Groups | 16 | 15.0 |
Hair/*enzymology | 3 | 42.0 |
*Blood Stains | 9 | 25.0 |
Duffy Blood-Group System/*genetics | 3 | 23.0 |
Breast Neoplasms/epidemiology/*genetics | 2 | 1.0 |
Genetic Markers/blood | 2 | 50.0 |
Nucleoside Deaminases/*blood | 2 | 40.0 |
Phosphoglucomutase/*blood/genetics | 2 | 100.0 |
Phosphotransferases/*blood | 2 | 25.0 |
Chromatography, Ion Exchange | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 12 | 0.0 |
Isoenzymes/*isolation & purification/metabolism | 2 | 25.0 |
Kinetics | 3 | 0.0 |
Phosphoglucomutase/*isolation & purification/metabolism | 2 | 100.0 |
Placenta/*enzymology | 3 | 3.0 |
Substrate Specificity | 3 | 0.0 |
Immunodiffusion | 2 | 0.0 |
Dental Pulp/analysis | 2 | 100.0 |
Forensic Medicine | 8 | 13.0 |
Hair/analysis | 2 | 40.0 |
Semen/analysis | 2 | 22.0 |
Statistics | 2 | 0.0 |
Hydrogen-Ion Concentration | 5 | 0.0 |
Age Factors | 5 | 0.0 |
alpha-L-Fucosidase/*genetics | 3 | 37.0 |
Israel | 4 | 2.0 |
Jews | 2 | 2.0 |
Korea | 2 | 0.0 |
Greece | 2 | 2.0 |
Chromatography, DEAE-Cellulose | 2 | 3.0 |
Time Factors | 2 | 0.0 |
Asia, Southeastern | 2 | 10.0 |
Phosphoglucomutase/analysis/*genetics | 3 | 100.0 |
Species Specificity | 2 | 0.0 |
Nucleoside-Phosphate Kinase/genetics | 2 | 40.0 |
Cats/genetics | 2 | 100.0 |
Foxes/*genetics | 2 | 66.0 |
*Genes | 5 | 2.0 |
Acid Phosphatase/blood/*genetics | 5 | 26.0 |
Blood Grouping and Crossmatching/methods | 3 | 23.0 |
*Bone Marrow Transplantation | 2 | 0.0 |
Adenylate Kinase/*genetics | 4 | 18.0 |
Phosphotransferases/*genetics | 5 | 11.0 |
Enzymes/blood/*genetics | 3 | 50.0 |
Blood Stains | 3 | 13.0 |
Phosphoglucomutase/*analysis | 3 | 50.0 |
*African Continental Ancestry Group | 6 | 5.0 |
Sudan | 3 | 16.0 |
Isoelectric Point | 5 | 4.0 |
Fertilization | 2 | 8.0 |
HLA Antigens/analysis | 2 | 0.0 |
Central African Republic | 3 | 42.0 |
Choriocarcinoma/genetics | 2 | 33.0 |
Adenosine Deaminase/blood/*genetics | 2 | 50.0 |
Nucleoside Deaminases/*genetics | 2 | 13.0 |
Isoenzymes/*blood/genetics | 2 | 18.0 |
Risk | 2 | 0.0 |
Hemoglobin, Sickle/genetics | 2 | 20.0 |
Sex Factors | 7 | 0.0 |
Genes, Structural | 6 | 0.0 |
Germany, West | 6 | 13.0 |
MNSs Blood-Group System | 3 | 60.0 |
P Blood-Group System | 3 | 75.0 |
Phosphoglucomutase | 3 | 37.0 |
Rh-Hr Blood-Group System | 9 | 25.0 |
*Chromosomes, Human, 1-3 | 20 | 35.0 |
Czechoslovakia | 2 | 11.0 |
ABO Blood-Group System | 3 | 4.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Glucosephosphate Dehydrogenase Deficiency/genetics | 2 | 6.0 |
Thalassemia/genetics | 2 | 25.0 |
Glucosephosphates/metabolism | 2 | 22.0 |
MNSs Blood-Group System/*genetics | 2 | 18.0 |
Phosphogluconate Dehydrogenase/blood/*genetics | 3 | 50.0 |
Thailand | 2 | 1.0 |
Genes | 3 | 1.0 |
Isoenzymes/analysis | 3 | 5.0 |
Phosphogluconate Dehydrogenase/analysis | 2 | 40.0 |
Pacific Islands | 2 | 25.0 |
*Blood Transfusion | 2 | 1.0 |
Transferrin/*genetics | 3 | 6.0 |
Kell Blood-Group System | 2 | 50.0 |
Vitamin D-Binding Protein | 6 | 21.0 |
Adenylate Kinase/blood/genetics | 2 | 66.0 |
Blood Grouping and Crossmatching/*methods | 2 | 7.0 |
Alpha-Globulins/*genetics | 2 | 12.0 |
Acid Phosphatase/*blood | 2 | 1.0 |
Enzymes/*blood | 3 | 25.0 |
*Forensic Medicine | 2 | 4.0 |
Granulocytes/*enzymology | 2 | 13.0 |
Naphthol AS D Esterase/blood | 2 | 66.0 |
T-Lymphocytes/*enzymology | 2 | 3.0 |
*Immunoglobulin Allotypes | 2 | 25.0 |
*Evolution | 2 | 1.0 |
Rwanda | 2 | 22.0 |
*Genes, Structural | 6 | 0.0 |
Genetics, Medical | 3 | 13.0 |
Glucosidases/*genetics | 2 | 15.0 |
Hybrid Cells/enzymology/ultrastructure | 2 | 50.0 |
beta-Glucosidase/*genetics | 2 | 50.0 |
Peptide Hydrolases/genetics | 2 | 22.0 |
*Asian Continental Ancestry Group | 2 | 3.0 |
*Chromosomes, Human, 6-12 and X | 4 | 2.0 |
*Translocation, Genetic | 3 | 0.0 |
*Jews | 3 | 6.0 |
Anthropometry | 2 | 0.0 |
Twins, Dizygotic | 2 | 5.0 |
Adenylate Kinase/blood | 6 | 60.0 |
Adenosine Deaminase/blood | 2 | 14.0 |
Esterases/blood | 5 | 41.0 |
Phosphogluconate Dehydrogenase/blood | 3 | 17.0 |
French Guiana | 2 | 66.0 |
Blood Group Antigens | 8 | 20.0 |
Electrophoresis | 4 | 1.0 |
Clone Cells | 3 | 0.0 |
Hybrid Cells/enzymology | 2 | 3.0 |
Pan troglodytes/*genetics | 2 | 7.0 |
Alanine Transaminase/blood | 4 | 2.0 |
Phosphopyruvate Hydratase/genetics | 2 | 15.0 |
Uridine Kinase/genetics | 2 | 100.0 |
Duffy Blood-Group System | 3 | 50.0 |
Blood Proteins | 2 | 7.0 |
Canada | 2 | 1.0 |
*Chromosome Aberrations | 3 | 0.0 |
Endopeptidases/metabolism | 2 | 1.0 |
Fumarate Hydratase/metabolism | 2 | 66.0 |
Phosphoglucomutase/metabolism | 2 | 40.0 |
Phosphogluconate Dehydrogenase/metabolism | 2 | 18.0 |
UTP-Glucose-1-Phosphate Uridylyltransferase/metabolism | 2 | 100.0 |
*Alanine Transaminase | 2 | 66.0 |
Molecular Biology | 2 | 0.0 |
Isoenzymes | 4 | 2.0 |
Malate Dehydrogenase | 2 | 100.0 |
*Rh-Hr Blood-Group System | 2 | 6.0 |
